Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study
- Five-years experiences of the Revised National Tuberculosis Control Programme in northern part of Kolkata, India. Pandit, Sudipta; Dey, Atin; Chaudhuri, Arunabha Datta; Saha, Mita; Sengupta, Amitava; Kundu, Sushmita; Bhuniya, Sourin; Shib Singh // Lung India;2009, Vol. 26 Issue 4, p109
Background: The Revised National Tuberculosis Control programme (RNTCP), India. Aim: To assess the impact of the expansion of the RNTCP in the case detection and treatment outcome. Materials and Methods: Reports of patients with tuberculosis (TB) diagnosed and treated under RNTCP from 2001 to...
- Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study. Vasankari, Tuula; Holmström, Pekka; Ollgren, Jukka; Liippo, Kari; Ruutu, Petri // BMC Public Health;2010, Vol. 10, p399
Background: We investigated the treatments given, the outcome and the patient- and treatment-system dependent factors affecting treatment outcome in a national two-year cohort of culture-verified extra-pulmonary tuberculosis cases in Finland. Methods: Medical records of all cases in 1995 -1996...
- A comparison between passive and active case finding in TB control in the Arkhangelsk region. Kuznetsov, Vladimir N.; Grjibovski, Andrej M.; Mariandyshev, Andrey O.; Johansson, Eva; Bjune, Gunnar A. // International Journal of Circumpolar Health;2014, Vol. 73, p1
Background. In Russia, active case finding (ACF) for certain population groups has been practiced uninterruptedly for many decades, but no studies comparing ACF and passive case finding (PCF) approaches in Russia have been published. Objective. The aim of this study was to describe the main...
- Multidrug resistant to extensively drug resistant tuberculosis: What is next? Jain, Amita; Dixit, Pratima // Journal of Biosciences;Nov2008, Vol. 33 Issue 4, p605
Drug resistant tuberculosis is a man made problem. While tuberculosis is hundred percent curable, multidrug resistant tuberculosis (MDR-TB) is difficult to treat. Inadequate and incomplete treatment and poor treatment adherence has led to a newer form of drug resistance known as extensively drug...
- Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. Sei Won Lee; Choon-Taek Lee; Jae-Joon Yim // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p300
Background: The role of interferon-Î³ release assay (IGRA) in monitoring responses to anti-tuberculosis (TB) treatment is not clear. We evaluated the results of the QuantiFERON-TB Gold In-tube (QFT-GIT) assay over time during the anti-TB treatment of adults with no underlying disease. Methods:...
- Sternal wound tuberculosis following cardiac operations: a review. Shi-Min Yuan // Brazilian Journal of Cardiovascular Surgery;2015, Vol. 30 Issue 4, p489
Objective: The diagnosis and treatment of sternal wound infections with mycobacteria are challenging. Such an infection is often associated with a delayed diagnosis and improper treatment that may lead to a worsened clinical outcome. The present study is designed to highlight its clinical...
- How does my doctor treat TB infection? // Tuberculosis: Getting Healthy, Staying Healthy;Jun2008, Issue 8, p6
The article provides an answer to a question of how physicians treat tuberculosis (TB) infection.
- A waiting room from hell. Sonkar, Madhulika // Asian Pacific Post;10/27/2011, p16
The article focuses on the case of 17-year-old Shehnaz, who has stayed outside the All India Institute of Medical Sciences (AIIMS) in New Delhi, India for 40 days just to be told by doctors that her bone tuberculosis is incurable.
- New tuberculosis tests reduce diagnostic costs. // PharmacoEconomics & Outcomes News;Mar2015, Vol. 724 Issue 1, p20
The article reports that using novel diagnostics for treating tuberculosis would reduce diagnostic costs.